FDAnews
www.fdanews.com/articles/138328-the-big-bet-on-seattle-genetics

The Big Bet on Seattle Genetics

July 12, 2011
Seattle Genetics lists seven drugs on its pipeline page. And there are another 11 clinical-stage drug candidates and quite a few preclinical ones being developed by partners from large companies, such as Roche, Pfizer and Abbott, in addition to smaller ones like Progenics Pharmaceuticals and Celldex Therapeutics.
The Motley Fool